Legacy Planning Guide
We know this isn't the most comfortable topic to sit down with. But if you've taken the time to open this page, you're already ahead of most people. Independent pharmacists face a dual challenge: the complexities of a regulated healthcare business and the personal financial planning most professionals need. Both require deliberate planning.
Every profession has its own blind spots when it comes to legacy planning. Here are the ones that come up most often for pharmacists — and the ones that tend to catch people off guard.
DEA controlled substance registration cannot be transferred — requires immediate DEA notification
Prescription records must be maintained even after sale or closure
Inventory of Schedule II-V drugs must be disposed of properly by a licensed pharmacist
PBM contracts may terminate automatically on owner death
Independent pharmacy goodwill tied to owner's relationships with physicians
You don't need to have everything perfect from day one — but having these documents in place means your family won't be left guessing when it matters most.
DEA diversion protocol and closure instructions for heirs
Buy-sell agreement with a licensed pharmacist successor
Prescription record retention and transfer plan
Inventory insurance rider covering drug stock value
Letter to staff explaining the pharmacy's values and patient care philosophy
These aren't meant to scare you — they're meant to protect you. Each one is a real scenario we've seen play out, and each one is completely avoidable.
No DEA closure plan — DEA agents arrive within 48 hours of death and pharmacy must comply
PBM contracts reviewed by no one — significant revenue streams evaporate
Prescription database locked to a software vendor with no handoff credentials
Life insurance insufficient to cover pharmacy inventory loans
No employee retention plan during a difficult ownership transition
Don't know where to start? These are the three most impactful moves for pharmacists who are just beginning to think about legacy planning.
Designate a successor pharmacist and contact your state pharmacy board for succession requirements
Document DEA notification and controlled substance inventory and disposal procedures
Get a professional pharmacy valuation from a specialist broker
What happens to my pharmacy if I die without a succession plan?
Your state pharmacy board will likely appoint a temporary manager. Without a pre-arranged successor, the pharmacy may be forced to close, destroying the business value your family could otherwise inherit through a structured sale.
Can an heir inherit a pharmacy?
Only if they are a licensed pharmacist in most states. Otherwise, the pharmacy must be sold to a licensed pharmacist or pharmacy chain. Your succession plan should include a pre-negotiated sale agreement with a qualified buyer.
How do I handle controlled substance inventory at death?
The DEA must be notified immediately. All Schedule II–V medications must be inventoried and disposed of through DEA-approved channels. This is a critical compliance issue that should be fully documented in your succession plan.
What is my pharmacy worth for estate planning purposes?
Independent pharmacies typically sell for 1–3x annual EBITDA, influenced by PBM contracts, prescription volume, and compounding capabilities. Get a formal valuation from a pharmacy business broker before finalizing your estate plan.
Ready when you are
AI-guided tools that help you create letters, plan your estate, and protect your business — all in plain language, all in your own words.
Start for $9.99/monthCancel anytime. Browser-first privacy.
Our AI-guided tools walk you through each document step by step — no legal jargon, no blank pages staring back at you. Here's what we recommend for pharmacists:
Important disclaimer
This content is for general informational purposes only and does not constitute legal, tax, or financial advice. It was created with the assistance of AI and may contain inaccuracies. Laws and regulations change frequently — always consult a qualified attorney or financial advisor before making estate planning decisions.